{"gene":"GABRA2","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2018,"finding":"A de novo missense variant in GABRA2 (p.T292K) reduces channel expression and produces mutant GABA-A receptor channels that are tonically open even in the absence of GABA, as demonstrated by whole-cell patch-clamp recordings in HEK293T cells expressing the mutant α2 subunit with β and γ subunits.","method":"Whole-cell patch-clamp electrophysiology in HEK293T cells expressing mutant GABRA2 constructs","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro functional assay (patch-clamp) with specific missense mutation, rigorous electrophysiological readout","pmids":["29961870"],"is_preprint":false},{"year":2005,"finding":"The human GABRA2 gene produces multiple mRNA isoforms through alternative splicing and alternative promoter use; at least four major isoforms arise from combinations of two alternative 5' and 3' exons, and two functional promoters drive differential expression in brain regions. Naturally occurring haplotypes differ in promoter activity, indicating that non-coding variants regulate GABRA2 expression.","method":"RT-PCR, DNA sequencing, and transient transfection promoter activity assays in human brain tissue samples","journal":"Brain research. Molecular brain research","confidence":"High","confidence_rationale":"Tier 1 — promoter activity directly measured by transfection assay with haplotype comparison, plus molecular characterization of splicing","pmids":["15950776"],"is_preprint":false},{"year":2002,"finding":"The rat Gabra2 gene has three alternative first exons, each with its own functional promoter, generating six mRNA isoforms that differ in their 5'-UTRs; differential activation of these alternative promoters is used during brain development, and the 5'-UTR diversity affects GABA-A receptor expression levels.","method":"RT-PCR, genomic sequencing, promoter characterization in rat brain, and expression analysis across developmental stages","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct promoter activity assays combined with developmental expression analysis showing functional consequences","pmids":["12354299"],"is_preprint":false},{"year":2008,"finding":"Targeted deletion of the GABRA2 gene (α2 subunit knockout) in mice abolishes the anxiolytic effects of both benzodiazepines (diazepam) and barbiturates (pentobarbital) in the conditioned emotional response test, demonstrating that α2-containing GABA-A receptors mediate anxiolytic actions of both drug classes.","method":"Genetic knockout (GABRA2 deletion) with behavioral pharmacology (conditioned emotional response, anxiolytic drug challenge) in mice","journal":"Pharmacology, biochemistry, and behavior","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific pharmacological phenotype readout, drug-dose response","pmids":["18313124"],"is_preprint":false},{"year":2012,"finding":"Deletion of the Gabra2 gene (α2 subunit knockout) in mice increases hypersensitivity to the acute sedative and ataxic effects of ethanol (shorter latency to fall on Rotarod, prolonged loss of righting reflex) without altering blood ethanol concentrations or ethanol self-administration, indicating a protective role for α2-containing GABA-A receptors against acute ethanol-induced motor impairment.","method":"Genetic knockout with Rotarod/wire hang behavioral assay, loss-of-righting-reflex test, blood alcohol concentration measurement, and operant ethanol self-administration in mice","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal behavioral assays plus pharmacokinetic controls in KO vs. WT mice","pmids":["23115637"],"is_preprint":false},{"year":2016,"finding":"Point mutations in Gabra2 affecting specific amino acid residues modulate distinct aspects of alcohol drinking behavior in mice: the H101R mutation (BZD-insensitive) escalates binge-like drinking; the Q241M mutation (neurosteroid-insensitive) blunts chronic ethanol intake; and S270H/L277A mutations (high-ethanol-insensitive) prevent forced-abstinence-induced social deficits, demonstrating residue-specific roles of α2-containing GABA-A receptors in alcohol-related behaviors.","method":"Point mutation knockin mice assessed with drinking in the dark, continuous access, and intermittent access alcohol drinking protocols, plus social approach testing","journal":"Alcoholism, clinical and experimental research","confidence":"High","confidence_rationale":"Tier 1 — multiple point mutations tested in vivo with multiple behavioral paradigms, causal mechanistic assignment to specific residues","pmids":["27717041"],"is_preprint":false},{"year":2021,"finding":"A B6-specific single nucleotide deletion within an intron of Gabra2 reduces mRNA and protein expression by ~50% and lowers the abundance of α2-containing GABA-A receptors in hippocampal synapses; CRISPR/Cas9 correction of this deletion restores expression and rescues epilepsy phenotypes in Scn1a+/- (Dravet syndrome model) mice, validating Gabra2 as a genetic modifier of Dravet syndrome severity.","method":"Quantitative Western blot and receptor abundance measurement, CRISPR/Cas9 knock-in correction, seizure and survival phenotyping in Scn1a+/- mice","journal":"Mammalian genome : official journal of the International Mammalian Genome Society","confidence":"High","confidence_rationale":"Tier 1 — CRISPR rescue experiment with molecular (protein level) and phenotypic readout, combined with receptor abundance quantification","pmids":["34086081"],"is_preprint":false},{"year":2020,"finding":"The same hypomorphic intronic deletion in Gabra2 (C57BL/6J strain) that reduces α2 subunit expression is associated with earlier seizure onset and shortened lifespan in Scn8a gain-of-function mutant mice; correction of the splice site variant restores transcript abundance, delays seizure onset, and extends survival, confirming Gabra2 as a modifier of SCN8A encephalopathy severity.","method":"QTL mapping, knock-in allele correction, RT-PCR transcript quantification, and survival/seizure onset phenotyping in Scn8a mutant mice","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 1/2 — QTL mapping plus allele correction with molecular and phenotypic validation","pmids":["33140451"],"is_preprint":false},{"year":2021,"finding":"A quantitative trait variant consisting of a functional intronic indel in Gabra2 underlies increased methamphetamine-induced locomotor sensitivity in mice; CRISPR/Cas9 correction of the mutant deletion on the C57BL/6J background to the wild-type allele was sufficient to reduce methamphetamine-induced locomotor activity, validating this variant as the causal quantitative trait variant.","method":"Genome-wide QTL analysis, cis-eQTL mapping in striatum, CRISPR/Cas9 allele correction, and methamphetamine locomotor activity assay","journal":"Genes, brain, and behavior","confidence":"High","confidence_rationale":"Tier 1 — CRISPR rescue experiment with causal variant validation and molecular + behavioral readout","pmids":["34677900"],"is_preprint":false},{"year":2020,"finding":"FRMD7 directly interacts with the intracellular loop between transmembrane domains 3 and 4 of the GABRA2 protein (a domain critical for receptor transport and localization), as shown by GST pull-down and co-immunoprecipitation; FRMD7 mutations associated with infantile nystagmus syndrome reduce this binding, and loss of the FRMD7 homologue frm-3 in C. elegans impairs GABA-A receptor localization (assessed by FRAP) and locomotion.","method":"GST pull-down, co-immunoprecipitation, western blotting, immunofluorescence localization, and C. elegans FRAP/locomotion rescue assays","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal pull-down and Co-IP identifying binding domain, combined with in vivo functional validation in C. elegans","pmids":["32446246"],"is_preprint":false},{"year":2015,"finding":"The alcohol-dependence-associated GABRA2 rs279858*C allele is associated with significantly lower GABRA2 mRNA levels in human iPSC-derived neural cell cultures, and expression of the entire chromosome 4p12 GABA-A subunit gene cluster (GABRG1, GABRA2, GABRA4, GABRB1) is correlated and co-regulated, with the C-allele defining a low-expression cluster. This effect was not observed in postmortem adult cortex, suggesting a developmental window for the genotypic effect on expression.","method":"qPCR and RNA sequencing in human iPSC-derived neural cell lines stratified by genotype; comparison with postmortem brain datasets","journal":"Alcoholism, clinical and experimental research","confidence":"Medium","confidence_rationale":"Tier 2 — genotype-stratified expression in human iPSC model with orthogonal RNA-seq confirmation, but single lab","pmids":["26250693"],"is_preprint":false},{"year":2015,"finding":"In mice, exercise increases Gabra2 mRNA expression in aged animals while decreasing it in young animals, and inhibition of the H3K9me3 methyltransferase SUV39H1 (ETP69 treatment) also reduces Gabra2 expression in young mice, suggesting that H3K9me3 at the Gabra2 promoter region is a repressive epigenetic regulator of Gabra2 transcription in an age-dependent manner.","method":"Chromatin immunoprecipitation (H3K9me3 at Gabra2 promoter), qPCR for mRNA, pharmacological inhibition (ETP69) in young and aged mice","journal":"Frontiers in aging neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP combined with qPCR and pharmacological intervention, single lab","pmids":["34970138"],"is_preprint":false},{"year":2015,"finding":"In mice, loss of GABRA2 (α2-subunit knockout) abolishes the ability of methylphenidate to facilitate conditioned reinforcement for stimuli associated with reward, mirroring the blunted motivational/reinforcing effects of methylphenidate seen in humans carrying GABRA2 addiction-risk SNPs, suggesting that α2-containing GABA-A receptors are required for psychostimulant-mediated enhancement of conditioned reinforcement circuits.","method":"α2 knockout mouse operant conditioned reinforcement paradigm combined with human pharmacogenetic study of methylphenidate subjective effects","journal":"Frontiers in behavioral neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — parallel human pharmacogenetics + mouse KO behavioral assay, convergent evidence from two species","pmids":["26635556"],"is_preprint":false},{"year":2015,"finding":"In zebrafish, gabra2 morpholino knockdown disrupts the pattern of neural proliferation and increases apoptosis in the mid- and hindbrain; it also alters expression of signaling pathway genes (notch1, pax2, fgf8, wnt1), downregulates the proneural gene neuroD, and reduces gad1b (GAD67) expression, indicating that gabra2 participates in CNS developmental signaling pathways regulating proliferation and neurogenesis.","method":"Morpholino knockdown in zebrafish embryos with proliferation markers, apoptosis assay, and gene expression analysis (qPCR/in situ hybridization)","journal":"Biochemistry and biophysics reports","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with multiple molecular readouts in zebrafish ortholog, consistent with mammalian context","pmids":["29124181"],"is_preprint":false},{"year":2005,"finding":"GABRA2 alleles (rs279858) modulate the subjective effects of alcohol in humans; individuals homozygous for the common A-allele experienced greater subjective alcohol effects than G-allele carriers, and finasteride (a 5α-reductase inhibitor that blocks neuroactive steroid synthesis) reduced subjective effects selectively in A-allele homozygotes, providing indirect evidence that neuroactive steroids mediate some subjective effects of alcohol through GABRA2-containing receptors.","method":"Randomized double-blind placebo-controlled human laboratory alcohol challenge with finasteride pretreatment, genotype-stratified analysis","journal":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — controlled human pharmacogenetic study with pharmacological manipulation; single lab, moderate sample","pmids":["15702134"],"is_preprint":false},{"year":2024,"finding":"A novel de novo GABRA2 missense variant (p.Ala308Val) in the extracellular domain reduces protein expression, impairs co-immunoprecipitation interactions with GABRB3 and GABRG2 subunits (suggesting destabilization of the pentameric receptor complex), but does not affect subcellular localization of the mutant α2 protein in transfected cells.","method":"Western blotting, co-immunoprecipitation, and immunofluorescence in transfected HEK293T cells with structural modeling","journal":"Annals of clinical and translational neurology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple molecular methods (Co-IP, WB, IF) in single study; provides mechanistic insight into subunit assembly","pmids":["39737842"],"is_preprint":false},{"year":2020,"finding":"Structural analysis of seven pathogenic missense variants in GABRA2 associated with early infantile epileptic encephalopathy showed that all variants localize to the transmembrane domain—near the desensitization gate, activation gate, or inter-subunit interfaces—positions equivalent to known pathogenic mutations in other Cys-loop receptors, indicating that disruption of these conserved structural elements underlies channel dysfunction.","method":"Protein structural modeling and comparative analysis with known pathogenic positions in other Cys-loop receptors; novel variant identified by trio whole-genome sequencing","journal":"Molecular genetics & genomic medicine","confidence":"Low","confidence_rationale":"Tier 4 — structural modeling without direct functional validation of channel activity","pmids":["32347641"],"is_preprint":false}],"current_model":"GABRA2 encodes the α2 subunit of the GABAA receptor, a ligand-gated chloride channel; it is expressed from multiple alternatively spliced transcripts driven by alternative promoters whose activity is regulated by haplotypic variation, and α2-containing receptors are required for the anxiolytic actions of benzodiazepines and barbiturates, modulate the subjective and motor-impairing effects of ethanol (with specific residues—H101, Q241, S270/L277—mediating distinct drug actions), facilitate psychostimulant-driven conditioned reinforcement, and act as a genetic modifier of epilepsy severity through regulation of inhibitory tone at hippocampal synapses; de novo missense variants in the transmembrane domain cause gain-of-function (tonic channel opening) or loss-of-function (reduced expression, impaired subunit assembly) leading to developmental and epileptic encephalopathy."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing that Gabra2 uses multiple alternative promoters and first exons to generate diverse 5′-UTR isoforms during brain development answered how α2 subunit expression is tuned across developmental stages and brain regions.","evidence":"RT-PCR, genomic sequencing, and promoter characterization in rat brain across developmental stages","pmids":["12354299"],"confidence":"High","gaps":["Human promoter architecture not yet characterized at this point","No link to specific transcription factor regulation","Functional consequences of individual isoforms on receptor assembly not tested"]},{"year":2005,"claim":"Demonstration that the human GABRA2 gene likewise uses alternative promoters and splicing, with haplotypic variation altering promoter activity, established a molecular basis for how non-coding genetic variants modulate GABRA2 expression and linked this to addiction-associated alleles.","evidence":"RT-PCR, DNA sequencing, and transient transfection promoter assays in human brain tissue; parallel human pharmacogenetic alcohol challenge study","pmids":["15950776","15702134"],"confidence":"High","gaps":["Which transcription factors bind differentially to risk haplotypes unknown","Precise cell-type-level expression effects of haplotypes not resolved"]},{"year":2008,"claim":"Gabra2 knockout mice losing both benzodiazepine and barbiturate anxiolytic responses established that α2-containing GABAA receptors are the obligate mediators of anxiolysis for both drug classes, not just benzodiazepines.","evidence":"Genetic knockout with conditioned emotional response behavioral pharmacology in mice","pmids":["18313124"],"confidence":"High","gaps":["Molecular mechanism by which α2 subunit selectively confers anxiolytic sensitivity unclear","Circuit-level locus of anxiolytic action not identified"]},{"year":2012,"claim":"Showing that α2 knockout increases sensitivity to ethanol's motor-impairing effects without changing blood ethanol levels or self-administration revealed that α2-containing receptors normally protect against acute ethanol-induced sedation and ataxia.","evidence":"Rotarod, loss-of-righting-reflex, blood alcohol concentration, and operant self-administration in Gabra2 KO vs WT mice","pmids":["23115637"],"confidence":"High","gaps":["Specific receptor subtype composition (α2βxγx) mediating ethanol sensitivity not defined","Whether compensatory upregulation of other subunits contributes to phenotype not examined"]},{"year":2015,"claim":"Multiple convergent findings established broader roles: rs279858*C allele reduces GABRA2 expression in human iPSC-derived neurons in a developmental window; α2 KO abolishes methylphenidate-facilitated conditioned reinforcement; and gabra2 knockdown in zebrafish disrupts neural proliferation and proneural gene expression, indicating roles beyond mature synaptic inhibition.","evidence":"Human iPSC qPCR/RNA-seq genotype-stratified analysis; mouse KO operant behavior; zebrafish morpholino knockdown with proliferation/apoptosis/gene expression assays","pmids":["26250693","26635556","29124181"],"confidence":"Medium","gaps":["Developmental signaling role in mammalian neurogenesis not confirmed with genetic models","iPSC expression effect not replicated in adult brain—developmental specificity vs technical limitation unclear","Morpholino off-target effects not excluded by genetic mutant"]},{"year":2015,"claim":"H3K9me3 enrichment at the Gabra2 promoter and its sensitivity to SUV39H1 inhibition identified an epigenetic layer of Gabra2 transcriptional regulation that operates in an age-dependent manner.","evidence":"ChIP for H3K9me3 at Gabra2 promoter, qPCR, and ETP69 pharmacological inhibition in young and aged mice","pmids":["34970138"],"confidence":"Medium","gaps":["Causal relationship between H3K9me3 and Gabra2 expression not established by genetic manipulation of the mark","Cell-type specificity of epigenetic regulation not resolved"]},{"year":2016,"claim":"Point-mutation knockin mice revealed that individual α2 residues control distinct facets of alcohol behavior—H101R escalates binge drinking, Q241M blunts chronic intake, S270H/L277A prevents abstinence-induced social deficits—decomposing the receptor's pharmacological interfaces into separable behavioral outputs.","evidence":"Multiple knockin lines assessed with drinking-in-the-dark, continuous access, intermittent access, and social approach paradigms","pmids":["27717041"],"confidence":"High","gaps":["Electrophysiological consequences of each knockin mutation on receptor function in vivo not measured","Whether these residues act via allosteric modulation or direct ethanol binding not distinguished"]},{"year":2018,"claim":"Identification of a de novo p.T292K variant that produces tonically open channels with reduced expression in vitro established the first gain-of-function disease mechanism for GABRA2, linking it to developmental and epileptic encephalopathy.","evidence":"Whole-cell patch-clamp in HEK293T cells expressing mutant α2β3γ2 receptors","pmids":["29961870"],"confidence":"High","gaps":["In vivo confirmation of tonic opening in neuronal context not performed","Whether tonic current causes excitotoxicity or shunting inhibition defect not resolved"]},{"year":2020,"claim":"FRMD7 was identified as a direct binding partner of the α2 intracellular TM3–TM4 loop, with mutations disrupting binding and causing GABAA receptor mislocalization, revealing a trafficking/anchoring partner for α2-containing receptors relevant to infantile nystagmus syndrome.","evidence":"GST pull-down, co-immunoprecipitation, and C. elegans FRAP/locomotion rescue assays","pmids":["32446246"],"confidence":"High","gaps":["Whether FRMD7 interaction is specific to α2 vs other GABAA α subunits not tested","Mammalian in vivo validation of receptor mislocalization upon FRMD7 loss not shown"]},{"year":2020,"claim":"CRISPR correction of a hypomorphic intronic indel in Gabra2 (C57BL/6J) that halves α2 expression rescued seizure severity and survival in both Scn1a and Scn8a encephalopathy models, causally validating Gabra2 as a genetic modifier of epilepsy through regulation of inhibitory synaptic receptor abundance.","evidence":"QTL mapping, quantitative Western blot, CRISPR/Cas9 allele correction, seizure/survival phenotyping in Scn1a+/− and Scn8a mutant mice","pmids":["34086081","33140451"],"confidence":"High","gaps":["Whether the modifier effect extends to other genetic epilepsies not tested","Specific synaptic vs extrasynaptic receptor populations affected not distinguished"]},{"year":2021,"claim":"Correction of the same Gabra2 intronic variant reduced methamphetamine-induced locomotor sensitization, extending the gene's modifier role beyond epilepsy to psychostimulant behavioral responses and confirming the causal QTL variant.","evidence":"Genome-wide QTL analysis, cis-eQTL mapping in striatum, CRISPR allele correction, methamphetamine locomotor assay","pmids":["34677900"],"confidence":"High","gaps":["Downstream circuit mechanism linking reduced α2 expression to enhanced psychostimulant sensitivity unclear","Whether dopaminergic or GABAergic neurons are the critical cell type not resolved"]},{"year":2024,"claim":"A novel p.A308V variant was shown to reduce α2 protein expression and impair co-immunoprecipitation with GABRB3 and GABRG2, establishing a loss-of-function mechanism through disrupted pentameric subunit assembly distinct from the gain-of-function tonic opening mechanism.","evidence":"Western blotting, co-immunoprecipitation, and immunofluorescence in transfected HEK293T cells","pmids":["39737842"],"confidence":"Medium","gaps":["Electrophysiological characterization of p.A308V not performed","Assembly defect not confirmed in neurons or brain tissue","Only one variant tested—generalizability to other extracellular-domain mutations unclear"]},{"year":null,"claim":"The structural basis for how individual α2 residues differentially transduce benzodiazepine, neurosteroid, and ethanol modulation into distinct behavioral outputs, and which neuronal populations and synaptic vs extrasynaptic receptor pools mediate each pharmacological phenotype, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the α2-containing receptor with drug ligands","Cell-type-specific conditional knockouts not yet reported","Developmental vs adult contributions of α2 to circuit function not dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,3,4,6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,9,6]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,4,5,6,7]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,13]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,6]}],"complexes":["GABAA receptor (α2βγ pentamer)"],"partners":["GABRB3","GABRG2","FRMD7"],"other_free_text":[]},"mechanistic_narrative":"GABRA2 encodes the α2 subunit of the GABAA receptor, a ligand-gated chloride channel central to inhibitory neurotransmission, drug response, and neurodevelopment. The gene is transcribed from multiple alternative promoters generating diverse mRNA isoforms whose expression varies across brain regions and developmental stages, with haplotypic variation and H3K9me3 epigenetic marks regulating promoter activity [PMID:15950776, PMID:12354299, PMID:34970138]. α2-containing GABAA receptors are required for the anxiolytic actions of benzodiazepines and barbiturates, modulate acute ethanol sensitivity through specific residues (H101, Q241, S270/L277), and facilitate psychostimulant-driven conditioned reinforcement; a hypomorphic intronic variant that halves α2 expression acts as a genetic modifier of epilepsy severity in Dravet and SCN8A encephalopathy models, rescuable by CRISPR correction [PMID:18313124, PMID:27717041, PMID:34086081, PMID:33140451]. De novo missense variants in the transmembrane domain cause developmental and epileptic encephalopathy through gain-of-function (tonic channel opening, p.T292K) or loss-of-function (reduced expression, impaired pentameric assembly with GABRB3/GABRG2, p.A308V) mechanisms [PMID:29961870, PMID:39737842]."},"prefetch_data":{"uniprot":{"accession":"P47869","full_name":"Gamma-aminobutyric acid receptor subunit alpha-2","aliases":["GABA(A) receptor subunit alpha-2","GABAAR subunit alpha-2"],"length_aa":451,"mass_kda":51.3,"function":"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:10449790, PubMed:29961870, PubMed:31032849). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:10449790). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). The alpha-2 subunit exhibits synaptogenic activity together with beta-2 and very little to no activity together with beta-3, the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane; Cytoplasmic vesicle membrane; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P47869/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRA2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRA2","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"618559","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79","url":"https://www.omim.org/entry/618559"},{"mim_id":"618557","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE78","url":"https://www.omim.org/entry/618557"},{"mim_id":"612820","title":"NEUROPLASTIN; NPTN","url":"https://www.omim.org/entry/612820"},{"mim_id":"600232","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2","url":"https://www.omim.org/entry/600232"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":37.3}],"url":"https://www.proteinatlas.org/search/GABRA2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P47869","domains":[{"cath_id":"2.70.170.10","chopping":"65-248","consensus_level":"high","plddt":93.5701,"start":65,"end":248},{"cath_id":"1.20.58.390","chopping":"251-340_417-441","consensus_level":"high","plddt":93.3749,"start":251,"end":441}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P47869","model_url":"https://alphafold.ebi.ac.uk/files/AF-P47869-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P47869-F1-predicted_aligned_error_v6.png","plddt_mean":83.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRA2","jax_strain_url":"https://www.jax.org/strain/search?query=GABRA2"},"sequence":{"accession":"P47869","fasta_url":"https://rest.uniprot.org/uniprotkb/P47869.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P47869/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P47869"}},"corpus_meta":[{"pmid":"15024690","id":"PMC_15024690","title":"Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15024690","citation_count":498,"is_preprint":false},{"pmid":"15274050","id":"PMC_15274050","title":"Allelic and haplotypic association of GABRA2 with alcohol dependence.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15274050","citation_count":231,"is_preprint":false},{"pmid":"16557364","id":"PMC_16557364","title":"The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages.","date":"2006","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16557364","citation_count":169,"is_preprint":false},{"pmid":"16395124","id":"PMC_16395124","title":"Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.","date":"2006","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16395124","citation_count":144,"is_preprint":false},{"pmid":"16622805","id":"PMC_16622805","title":"Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample.","date":"2006","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16622805","citation_count":127,"is_preprint":false},{"pmid":"17207817","id":"PMC_17207817","title":"GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence.","date":"2007","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17207817","citation_count":123,"is_preprint":false},{"pmid":"15702134","id":"PMC_15702134","title":"GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride.","date":"2005","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15702134","citation_count":121,"is_preprint":false},{"pmid":"19487630","id":"PMC_19487630","title":"Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring.","date":"2009","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19487630","citation_count":104,"is_preprint":false},{"pmid":"21483437","id":"PMC_21483437","title":"Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism.","date":"2011","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21483437","citation_count":102,"is_preprint":false},{"pmid":"19833324","id":"PMC_19833324","title":"The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19833324","citation_count":100,"is_preprint":false},{"pmid":"16874763","id":"PMC_16874763","title":"Dimensional anxiety mediates linkage of GABRA2 haplotypes with alcoholism.","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16874763","citation_count":88,"is_preprint":false},{"pmid":"29961870","id":"PMC_29961870","title":"De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29961870","citation_count":83,"is_preprint":false},{"pmid":"16562401","id":"PMC_16562401","title":"Marital status, alcohol dependence, and GABRA2: evidence for gene-environment correlation and interaction.","date":"2006","source":"Journal of studies on alcohol","url":"https://pubmed.ncbi.nlm.nih.gov/16562401","citation_count":82,"is_preprint":false},{"pmid":"24136292","id":"PMC_24136292","title":"Association of gamma-aminobutyric acid A receptor α2 gene (GABRA2) with alcohol use disorder.","date":"2013","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24136292","citation_count":78,"is_preprint":false},{"pmid":"17507911","id":"PMC_17507911","title":"Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17507911","citation_count":76,"is_preprint":false},{"pmid":"18818659","id":"PMC_18818659","title":"GABRG1 and GABRA2 as independent predictors for alcoholism in two populations.","date":"2008","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18818659","citation_count":75,"is_preprint":false},{"pmid":"17949392","id":"PMC_17949392","title":"Variation in GABRA2 predicts drinking behavior in project MATCH subjects.","date":"2007","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/17949392","citation_count":68,"is_preprint":false},{"pmid":"21118274","id":"PMC_21118274","title":"Role of GABRA2 in moderating subjective responses to alcohol.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/21118274","citation_count":51,"is_preprint":false},{"pmid":"20698837","id":"PMC_20698837","title":"A polymorphism in GABRA2 is associated with the medial frontal response to alcohol cues in an fMRI study.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/20698837","citation_count":50,"is_preprint":false},{"pmid":"18727688","id":"PMC_18727688","title":"The role of GABRA2 in alcohol dependence, smoking, and illicit drug use in an Australian population sample.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/18727688","citation_count":46,"is_preprint":false},{"pmid":"18313124","id":"PMC_18313124","title":"Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.","date":"2008","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/18313124","citation_count":46,"is_preprint":false},{"pmid":"23561058","id":"PMC_23561058","title":"How phenotype and developmental stage affect the genes we find: GABRA2 and impulsivity.","date":"2013","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/23561058","citation_count":42,"is_preprint":false},{"pmid":"22501025","id":"PMC_22501025","title":"GABRA2 markers moderate the subjective effects of alcohol.","date":"2012","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/22501025","citation_count":42,"is_preprint":false},{"pmid":"17690794","id":"PMC_17690794","title":"The role of the GABRA2 polymorphism in multiplex alcohol dependence families with minimal comorbidity: within-family association and linkage analyses.","date":"2007","source":"Journal of studies on alcohol and drugs","url":"https://pubmed.ncbi.nlm.nih.gov/17690794","citation_count":37,"is_preprint":false},{"pmid":"23692184","id":"PMC_23692184","title":"Genetic influences on alcohol use across stages of development: GABRA2 and longitudinal trajectories of drunkenness from adolescence to young adulthood.","date":"2013","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/23692184","citation_count":37,"is_preprint":false},{"pmid":"21919924","id":"PMC_21919924","title":"GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans.","date":"2011","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/21919924","citation_count":33,"is_preprint":false},{"pmid":"24166645","id":"PMC_24166645","title":"A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.","date":"2013","source":"Alcohol and alcoholism (Oxford, Oxfordshire)","url":"https://pubmed.ncbi.nlm.nih.gov/24166645","citation_count":31,"is_preprint":false},{"pmid":"26250693","id":"PMC_26250693","title":"GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures.","date":"2015","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/26250693","citation_count":30,"is_preprint":false},{"pmid":"15950776","id":"PMC_15950776","title":"Alternative splicing and promoter use in the human GABRA2 gene.","date":"2005","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15950776","citation_count":29,"is_preprint":false},{"pmid":"23974430","id":"PMC_23974430","title":"Gender-specific gene-environment interaction in alcohol dependence: the impact of daily life events and GABRA2.","date":"2013","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23974430","citation_count":27,"is_preprint":false},{"pmid":"21683760","id":"PMC_21683760","title":"Genetic association study of GABRA2 single nucleotide polymorphisms and electroencephalography in alcohol dependence.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21683760","citation_count":26,"is_preprint":false},{"pmid":"29422393","id":"PMC_29422393","title":"A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorder.","date":"2017","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/29422393","citation_count":26,"is_preprint":false},{"pmid":"29124181","id":"PMC_29124181","title":"Role of gabra2, GABAA receptor alpha-2 subunit, in CNS development.","date":"2015","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/29124181","citation_count":24,"is_preprint":false},{"pmid":"22555154","id":"PMC_22555154","title":"Gamma-aminobutyric acid A receptor, α-2 (GABRA2) variants as individual markers for alcoholism: a meta-analysis.","date":"2012","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22555154","citation_count":22,"is_preprint":false},{"pmid":"24811113","id":"PMC_24811113","title":"Rule breaking mediates the developmental association between GABRA2 and adolescent substance abuse.","date":"2014","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/24811113","citation_count":21,"is_preprint":false},{"pmid":"34086081","id":"PMC_34086081","title":"Gabra2 is a genetic modifier of Dravet syndrome in mice.","date":"2021","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/34086081","citation_count":21,"is_preprint":false},{"pmid":"25797587","id":"PMC_25797587","title":"Susceptibility effects of GABA receptor subunit alpha-2 (GABRA2) variants and parental monitoring on externalizing behavior trajectories: Risk and protection conveyed by the minor allele.","date":"2015","source":"Development and psychopathology","url":"https://pubmed.ncbi.nlm.nih.gov/25797587","citation_count":21,"is_preprint":false},{"pmid":"26087834","id":"PMC_26087834","title":"Adaptation of Subjective Responses to Alcohol is Affected by an Interaction of GABRA2 Genotype and Recent Drinking.","date":"2015","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/26087834","citation_count":20,"is_preprint":false},{"pmid":"33140451","id":"PMC_33140451","title":"Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.","date":"2020","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/33140451","citation_count":20,"is_preprint":false},{"pmid":"19783384","id":"PMC_19783384","title":"Test of association between GABRA2 (SNP rs279871) and adolescent conduct/alcohol use disorders utilizing a sample of clinic referred youth with serious substance and conduct problems, controls and available first degree relatives.","date":"2009","source":"Drug and alcohol dependence","url":"https://pubmed.ncbi.nlm.nih.gov/19783384","citation_count":20,"is_preprint":false},{"pmid":"17976953","id":"PMC_17976953","title":"Interpopulation linkage disequilibrium patterns of GABRA2 and GABRG1 genes at the GABA cluster locus on human chromosome 4.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17976953","citation_count":19,"is_preprint":false},{"pmid":"23115637","id":"PMC_23115637","title":"Deletion of the gabra2 gene results in hypersensitivity to the acute effects of ethanol but does not alter ethanol self administration.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23115637","citation_count":19,"is_preprint":false},{"pmid":"28237505","id":"PMC_28237505","title":"Stressful life events increase aggression and alcohol use in young carriers of the GABRA2 rs279826/rs279858 A-allele.","date":"2017","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28237505","citation_count":19,"is_preprint":false},{"pmid":"18361719","id":"PMC_18361719","title":"Effects of GABRA2 variation on physiological, psychomotor and subjective responses in the alcohol challenge twin study.","date":"2008","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/18361719","citation_count":18,"is_preprint":false},{"pmid":"25365806","id":"PMC_25365806","title":"Genetic variation in GABRA2 moderates peer influence on externalizing behavior in adolescents.","date":"2014","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/25365806","citation_count":16,"is_preprint":false},{"pmid":"20102561","id":"PMC_20102561","title":"GABRA2 and alcohol use disorders: no evidence of an association in an Italian case-control study.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/20102561","citation_count":16,"is_preprint":false},{"pmid":"28185103","id":"PMC_28185103","title":"PROSPER Intervention Effects on Adolescents' Alcohol Misuse Vary by GABRA2 Genotype and Age.","date":"2018","source":"Prevention science : the official journal of the Society for Prevention Research","url":"https://pubmed.ncbi.nlm.nih.gov/28185103","citation_count":14,"is_preprint":false},{"pmid":"29528673","id":"PMC_29528673","title":"GABRA2, alcohol, and illicit drug use: An event-level model of genetic risk for polysubstance use.","date":"2018","source":"Journal of abnormal psychology","url":"https://pubmed.ncbi.nlm.nih.gov/29528673","citation_count":14,"is_preprint":false},{"pmid":"26116794","id":"PMC_26116794","title":"Association of GABAA receptor α2 subunit gene (GABRA2) with alcohol dependence-related aggressive behavior.","date":"2015","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26116794","citation_count":11,"is_preprint":false},{"pmid":"24687270","id":"PMC_24687270","title":"Examination of genetic variation in GABRA2 with conduct disorder and alcohol abuse and dependence in a longitudinal study.","date":"2014","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24687270","citation_count":11,"is_preprint":false},{"pmid":"27717041","id":"PMC_27717041","title":"Effects of Gabra2 Point Mutations on Alcohol Intake: Increased Binge-Like and Blunted Chronic Drinking by Mice.","date":"2016","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/27717041","citation_count":10,"is_preprint":false},{"pmid":"32446246","id":"PMC_32446246","title":"FRMD7 Mutations Disrupt the Interaction with GABRA2 and May Result in Infantile Nystagmus Syndrome.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32446246","citation_count":9,"is_preprint":false},{"pmid":"29131352","id":"PMC_29131352","title":"GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers.","date":"2017","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/29131352","citation_count":9,"is_preprint":false},{"pmid":"32347641","id":"PMC_32347641","title":"Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate.","date":"2020","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32347641","citation_count":9,"is_preprint":false},{"pmid":"27581089","id":"PMC_27581089","title":"Beyond risk: Prospective effects of GABA Receptor Subunit Alpha-2 (GABRA2) × Positive Peer Involvement on adolescent behavior.","date":"2016","source":"Development and psychopathology","url":"https://pubmed.ncbi.nlm.nih.gov/27581089","citation_count":9,"is_preprint":false},{"pmid":"34970138","id":"PMC_34970138","title":"Exercise Reduces H3K9me3 and Regulates Brain Derived Neurotrophic Factor and GABRA2 in an Age Dependent Manner.","date":"2021","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34970138","citation_count":8,"is_preprint":false},{"pmid":"12354299","id":"PMC_12354299","title":"The 5'-flanking region of the rat GABA(A) receptor alpha2-subunit gene (Gabra2).","date":"2002","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12354299","citation_count":8,"is_preprint":false},{"pmid":"30555510","id":"PMC_30555510","title":"Sex and β-Endorphin Influence the Effects of Ethanol on Limbic Gabra2 Expression in a Mouse Binge Drinking Model.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30555510","citation_count":8,"is_preprint":false},{"pmid":"34677900","id":"PMC_34677900","title":"A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity.","date":"2021","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/34677900","citation_count":7,"is_preprint":false},{"pmid":"25804982","id":"PMC_25804982","title":"Mechanisms in the relation between GABRA2 and adolescent externalizing problems.","date":"2015","source":"European child & adolescent psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25804982","citation_count":6,"is_preprint":false},{"pmid":"10447508","id":"PMC_10447508","title":"A sequence-ready BAC contig of the GABAA receptor gene cluster Gabrg1-Gabra2-Gabrb1 on mouse chromosome 5.","date":"1999","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/10447508","citation_count":6,"is_preprint":false},{"pmid":"26635556","id":"PMC_26635556","title":"Motivational Effects of Methylphenidate are Associated with GABRA2 Variants Conferring Addiction Risk.","date":"2015","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26635556","citation_count":5,"is_preprint":false},{"pmid":"28847377","id":"PMC_28847377","title":"A GABRA2 polymorphism improves a model for prediction of drinking initiation.","date":"2017","source":"Alcohol (Fayetteville, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28847377","citation_count":5,"is_preprint":false},{"pmid":"35047853","id":"PMC_35047853","title":"Correction of the hypomorphic Gabra2 splice site variant in mouse strain C57BL/6J modifies the severity of Scn8a encephalopathy.","date":"2021","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/35047853","citation_count":4,"is_preprint":false},{"pmid":"34557020","id":"PMC_34557020","title":"The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction.","date":"2021","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34557020","citation_count":4,"is_preprint":false},{"pmid":"35873555","id":"PMC_35873555","title":"CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35873555","citation_count":2,"is_preprint":false},{"pmid":"40528577","id":"PMC_40528577","title":"GABRA2-related encephalopathy: Identification of two phenotypes with distinctive electroclinical features.","date":"2025","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/40528577","citation_count":2,"is_preprint":false},{"pmid":"30244312","id":"PMC_30244312","title":"Developmental Change in Adolescent Delinquency: Modeling Time-Varying Effects of a Preventative Intervention and GABRA2 Halpotype Linked to Alcohol Use.","date":"2018","source":"Journal of youth and adolescence","url":"https://pubmed.ncbi.nlm.nih.gov/30244312","citation_count":2,"is_preprint":false},{"pmid":"36422192","id":"PMC_36422192","title":"Prospective DNA Methylation Analysis of the CpG GABRA2 Receptor Subunit in Alcohol Dependence during Detoxification.","date":"2022","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/36422192","citation_count":0,"is_preprint":false},{"pmid":"39261011","id":"PMC_39261011","title":"5,7,3',4',5'-Pentamethoxyflavone, a Flavonoid Monomer Extracted From Murraya paniculata (L.) Jack, Alleviates Anxiety Through the A2AR/Gephyrin/GABRA2 Pathway.","date":"2024","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/39261011","citation_count":0,"is_preprint":false},{"pmid":"39737842","id":"PMC_39737842","title":"A novel de novo GABRA2 gene missense variant causing developmental epileptic encephalopathy in a Chinese patient.","date":"2024","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39737842","citation_count":0,"is_preprint":false},{"pmid":"31598057","id":"PMC_31598057","title":"Romantic Partner Alcohol Misuse Interacts with GABRA2 Genotype to Predict Frequency of Drunkenness in Young Adulthood.","date":"2018","source":"Journal of contemporary criminal justice","url":"https://pubmed.ncbi.nlm.nih.gov/31598057","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":38527,"output_tokens":4407,"usd":0.090843},"stage2":{"model":"claude-opus-4-6","input_tokens":7906,"output_tokens":3174,"usd":0.17832},"total_usd":0.269163,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"A de novo missense variant in GABRA2 (p.T292K) reduces channel expression and produces mutant GABA-A receptor channels that are tonically open even in the absence of GABA, as demonstrated by whole-cell patch-clamp recordings in HEK293T cells expressing the mutant α2 subunit with β and γ subunits.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology in HEK293T cells expressing mutant GABRA2 constructs\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro functional assay (patch-clamp) with specific missense mutation, rigorous electrophysiological readout\",\n      \"pmids\": [\"29961870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The human GABRA2 gene produces multiple mRNA isoforms through alternative splicing and alternative promoter use; at least four major isoforms arise from combinations of two alternative 5' and 3' exons, and two functional promoters drive differential expression in brain regions. Naturally occurring haplotypes differ in promoter activity, indicating that non-coding variants regulate GABRA2 expression.\",\n      \"method\": \"RT-PCR, DNA sequencing, and transient transfection promoter activity assays in human brain tissue samples\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — promoter activity directly measured by transfection assay with haplotype comparison, plus molecular characterization of splicing\",\n      \"pmids\": [\"15950776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The rat Gabra2 gene has three alternative first exons, each with its own functional promoter, generating six mRNA isoforms that differ in their 5'-UTRs; differential activation of these alternative promoters is used during brain development, and the 5'-UTR diversity affects GABA-A receptor expression levels.\",\n      \"method\": \"RT-PCR, genomic sequencing, promoter characterization in rat brain, and expression analysis across developmental stages\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct promoter activity assays combined with developmental expression analysis showing functional consequences\",\n      \"pmids\": [\"12354299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Targeted deletion of the GABRA2 gene (α2 subunit knockout) in mice abolishes the anxiolytic effects of both benzodiazepines (diazepam) and barbiturates (pentobarbital) in the conditioned emotional response test, demonstrating that α2-containing GABA-A receptors mediate anxiolytic actions of both drug classes.\",\n      \"method\": \"Genetic knockout (GABRA2 deletion) with behavioral pharmacology (conditioned emotional response, anxiolytic drug challenge) in mice\",\n      \"journal\": \"Pharmacology, biochemistry, and behavior\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific pharmacological phenotype readout, drug-dose response\",\n      \"pmids\": [\"18313124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Deletion of the Gabra2 gene (α2 subunit knockout) in mice increases hypersensitivity to the acute sedative and ataxic effects of ethanol (shorter latency to fall on Rotarod, prolonged loss of righting reflex) without altering blood ethanol concentrations or ethanol self-administration, indicating a protective role for α2-containing GABA-A receptors against acute ethanol-induced motor impairment.\",\n      \"method\": \"Genetic knockout with Rotarod/wire hang behavioral assay, loss-of-righting-reflex test, blood alcohol concentration measurement, and operant ethanol self-administration in mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal behavioral assays plus pharmacokinetic controls in KO vs. WT mice\",\n      \"pmids\": [\"23115637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Point mutations in Gabra2 affecting specific amino acid residues modulate distinct aspects of alcohol drinking behavior in mice: the H101R mutation (BZD-insensitive) escalates binge-like drinking; the Q241M mutation (neurosteroid-insensitive) blunts chronic ethanol intake; and S270H/L277A mutations (high-ethanol-insensitive) prevent forced-abstinence-induced social deficits, demonstrating residue-specific roles of α2-containing GABA-A receptors in alcohol-related behaviors.\",\n      \"method\": \"Point mutation knockin mice assessed with drinking in the dark, continuous access, and intermittent access alcohol drinking protocols, plus social approach testing\",\n      \"journal\": \"Alcoholism, clinical and experimental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple point mutations tested in vivo with multiple behavioral paradigms, causal mechanistic assignment to specific residues\",\n      \"pmids\": [\"27717041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A B6-specific single nucleotide deletion within an intron of Gabra2 reduces mRNA and protein expression by ~50% and lowers the abundance of α2-containing GABA-A receptors in hippocampal synapses; CRISPR/Cas9 correction of this deletion restores expression and rescues epilepsy phenotypes in Scn1a+/- (Dravet syndrome model) mice, validating Gabra2 as a genetic modifier of Dravet syndrome severity.\",\n      \"method\": \"Quantitative Western blot and receptor abundance measurement, CRISPR/Cas9 knock-in correction, seizure and survival phenotyping in Scn1a+/- mice\",\n      \"journal\": \"Mammalian genome : official journal of the International Mammalian Genome Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — CRISPR rescue experiment with molecular (protein level) and phenotypic readout, combined with receptor abundance quantification\",\n      \"pmids\": [\"34086081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The same hypomorphic intronic deletion in Gabra2 (C57BL/6J strain) that reduces α2 subunit expression is associated with earlier seizure onset and shortened lifespan in Scn8a gain-of-function mutant mice; correction of the splice site variant restores transcript abundance, delays seizure onset, and extends survival, confirming Gabra2 as a modifier of SCN8A encephalopathy severity.\",\n      \"method\": \"QTL mapping, knock-in allele correction, RT-PCR transcript quantification, and survival/seizure onset phenotyping in Scn8a mutant mice\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — QTL mapping plus allele correction with molecular and phenotypic validation\",\n      \"pmids\": [\"33140451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A quantitative trait variant consisting of a functional intronic indel in Gabra2 underlies increased methamphetamine-induced locomotor sensitivity in mice; CRISPR/Cas9 correction of the mutant deletion on the C57BL/6J background to the wild-type allele was sufficient to reduce methamphetamine-induced locomotor activity, validating this variant as the causal quantitative trait variant.\",\n      \"method\": \"Genome-wide QTL analysis, cis-eQTL mapping in striatum, CRISPR/Cas9 allele correction, and methamphetamine locomotor activity assay\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — CRISPR rescue experiment with causal variant validation and molecular + behavioral readout\",\n      \"pmids\": [\"34677900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FRMD7 directly interacts with the intracellular loop between transmembrane domains 3 and 4 of the GABRA2 protein (a domain critical for receptor transport and localization), as shown by GST pull-down and co-immunoprecipitation; FRMD7 mutations associated with infantile nystagmus syndrome reduce this binding, and loss of the FRMD7 homologue frm-3 in C. elegans impairs GABA-A receptor localization (assessed by FRAP) and locomotion.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, western blotting, immunofluorescence localization, and C. elegans FRAP/locomotion rescue assays\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal pull-down and Co-IP identifying binding domain, combined with in vivo functional validation in C. elegans\",\n      \"pmids\": [\"32446246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The alcohol-dependence-associated GABRA2 rs279858*C allele is associated with significantly lower GABRA2 mRNA levels in human iPSC-derived neural cell cultures, and expression of the entire chromosome 4p12 GABA-A subunit gene cluster (GABRG1, GABRA2, GABRA4, GABRB1) is correlated and co-regulated, with the C-allele defining a low-expression cluster. This effect was not observed in postmortem adult cortex, suggesting a developmental window for the genotypic effect on expression.\",\n      \"method\": \"qPCR and RNA sequencing in human iPSC-derived neural cell lines stratified by genotype; comparison with postmortem brain datasets\",\n      \"journal\": \"Alcoholism, clinical and experimental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genotype-stratified expression in human iPSC model with orthogonal RNA-seq confirmation, but single lab\",\n      \"pmids\": [\"26250693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In mice, exercise increases Gabra2 mRNA expression in aged animals while decreasing it in young animals, and inhibition of the H3K9me3 methyltransferase SUV39H1 (ETP69 treatment) also reduces Gabra2 expression in young mice, suggesting that H3K9me3 at the Gabra2 promoter region is a repressive epigenetic regulator of Gabra2 transcription in an age-dependent manner.\",\n      \"method\": \"Chromatin immunoprecipitation (H3K9me3 at Gabra2 promoter), qPCR for mRNA, pharmacological inhibition (ETP69) in young and aged mice\",\n      \"journal\": \"Frontiers in aging neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP combined with qPCR and pharmacological intervention, single lab\",\n      \"pmids\": [\"34970138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In mice, loss of GABRA2 (α2-subunit knockout) abolishes the ability of methylphenidate to facilitate conditioned reinforcement for stimuli associated with reward, mirroring the blunted motivational/reinforcing effects of methylphenidate seen in humans carrying GABRA2 addiction-risk SNPs, suggesting that α2-containing GABA-A receptors are required for psychostimulant-mediated enhancement of conditioned reinforcement circuits.\",\n      \"method\": \"α2 knockout mouse operant conditioned reinforcement paradigm combined with human pharmacogenetic study of methylphenidate subjective effects\",\n      \"journal\": \"Frontiers in behavioral neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — parallel human pharmacogenetics + mouse KO behavioral assay, convergent evidence from two species\",\n      \"pmids\": [\"26635556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In zebrafish, gabra2 morpholino knockdown disrupts the pattern of neural proliferation and increases apoptosis in the mid- and hindbrain; it also alters expression of signaling pathway genes (notch1, pax2, fgf8, wnt1), downregulates the proneural gene neuroD, and reduces gad1b (GAD67) expression, indicating that gabra2 participates in CNS developmental signaling pathways regulating proliferation and neurogenesis.\",\n      \"method\": \"Morpholino knockdown in zebrafish embryos with proliferation markers, apoptosis assay, and gene expression analysis (qPCR/in situ hybridization)\",\n      \"journal\": \"Biochemistry and biophysics reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple molecular readouts in zebrafish ortholog, consistent with mammalian context\",\n      \"pmids\": [\"29124181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GABRA2 alleles (rs279858) modulate the subjective effects of alcohol in humans; individuals homozygous for the common A-allele experienced greater subjective alcohol effects than G-allele carriers, and finasteride (a 5α-reductase inhibitor that blocks neuroactive steroid synthesis) reduced subjective effects selectively in A-allele homozygotes, providing indirect evidence that neuroactive steroids mediate some subjective effects of alcohol through GABRA2-containing receptors.\",\n      \"method\": \"Randomized double-blind placebo-controlled human laboratory alcohol challenge with finasteride pretreatment, genotype-stratified analysis\",\n      \"journal\": \"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — controlled human pharmacogenetic study with pharmacological manipulation; single lab, moderate sample\",\n      \"pmids\": [\"15702134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A novel de novo GABRA2 missense variant (p.Ala308Val) in the extracellular domain reduces protein expression, impairs co-immunoprecipitation interactions with GABRB3 and GABRG2 subunits (suggesting destabilization of the pentameric receptor complex), but does not affect subcellular localization of the mutant α2 protein in transfected cells.\",\n      \"method\": \"Western blotting, co-immunoprecipitation, and immunofluorescence in transfected HEK293T cells with structural modeling\",\n      \"journal\": \"Annals of clinical and translational neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular methods (Co-IP, WB, IF) in single study; provides mechanistic insight into subunit assembly\",\n      \"pmids\": [\"39737842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Structural analysis of seven pathogenic missense variants in GABRA2 associated with early infantile epileptic encephalopathy showed that all variants localize to the transmembrane domain—near the desensitization gate, activation gate, or inter-subunit interfaces—positions equivalent to known pathogenic mutations in other Cys-loop receptors, indicating that disruption of these conserved structural elements underlies channel dysfunction.\",\n      \"method\": \"Protein structural modeling and comparative analysis with known pathogenic positions in other Cys-loop receptors; novel variant identified by trio whole-genome sequencing\",\n      \"journal\": \"Molecular genetics & genomic medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — structural modeling without direct functional validation of channel activity\",\n      \"pmids\": [\"32347641\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRA2 encodes the α2 subunit of the GABAA receptor, a ligand-gated chloride channel; it is expressed from multiple alternatively spliced transcripts driven by alternative promoters whose activity is regulated by haplotypic variation, and α2-containing receptors are required for the anxiolytic actions of benzodiazepines and barbiturates, modulate the subjective and motor-impairing effects of ethanol (with specific residues—H101, Q241, S270/L277—mediating distinct drug actions), facilitate psychostimulant-driven conditioned reinforcement, and act as a genetic modifier of epilepsy severity through regulation of inhibitory tone at hippocampal synapses; de novo missense variants in the transmembrane domain cause gain-of-function (tonic channel opening) or loss-of-function (reduced expression, impaired subunit assembly) leading to developmental and epileptic encephalopathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRA2 encodes the α2 subunit of the GABAA receptor, a ligand-gated chloride channel central to inhibitory neurotransmission, drug response, and neurodevelopment. The gene is transcribed from multiple alternative promoters generating diverse mRNA isoforms whose expression varies across brain regions and developmental stages, with haplotypic variation and H3K9me3 epigenetic marks regulating promoter activity [PMID:15950776, PMID:12354299, PMID:34970138]. α2-containing GABAA receptors are required for the anxiolytic actions of benzodiazepines and barbiturates, modulate acute ethanol sensitivity through specific residues (H101, Q241, S270/L277), and facilitate psychostimulant-driven conditioned reinforcement; a hypomorphic intronic variant that halves α2 expression acts as a genetic modifier of epilepsy severity in Dravet and SCN8A encephalopathy models, rescuable by CRISPR correction [PMID:18313124, PMID:27717041, PMID:34086081, PMID:33140451]. De novo missense variants in the transmembrane domain cause developmental and epileptic encephalopathy through gain-of-function (tonic channel opening, p.T292K) or loss-of-function (reduced expression, impaired pentameric assembly with GABRB3/GABRG2, p.A308V) mechanisms [PMID:29961870, PMID:39737842].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that Gabra2 uses multiple alternative promoters and first exons to generate diverse 5′-UTR isoforms during brain development answered how α2 subunit expression is tuned across developmental stages and brain regions.\",\n      \"evidence\": \"RT-PCR, genomic sequencing, and promoter characterization in rat brain across developmental stages\",\n      \"pmids\": [\"12354299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human promoter architecture not yet characterized at this point\", \"No link to specific transcription factor regulation\", \"Functional consequences of individual isoforms on receptor assembly not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that the human GABRA2 gene likewise uses alternative promoters and splicing, with haplotypic variation altering promoter activity, established a molecular basis for how non-coding genetic variants modulate GABRA2 expression and linked this to addiction-associated alleles.\",\n      \"evidence\": \"RT-PCR, DNA sequencing, and transient transfection promoter assays in human brain tissue; parallel human pharmacogenetic alcohol challenge study\",\n      \"pmids\": [\"15950776\", \"15702134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which transcription factors bind differentially to risk haplotypes unknown\", \"Precise cell-type-level expression effects of haplotypes not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Gabra2 knockout mice losing both benzodiazepine and barbiturate anxiolytic responses established that α2-containing GABAA receptors are the obligate mediators of anxiolysis for both drug classes, not just benzodiazepines.\",\n      \"evidence\": \"Genetic knockout with conditioned emotional response behavioral pharmacology in mice\",\n      \"pmids\": [\"18313124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which α2 subunit selectively confers anxiolytic sensitivity unclear\", \"Circuit-level locus of anxiolytic action not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that α2 knockout increases sensitivity to ethanol's motor-impairing effects without changing blood ethanol levels or self-administration revealed that α2-containing receptors normally protect against acute ethanol-induced sedation and ataxia.\",\n      \"evidence\": \"Rotarod, loss-of-righting-reflex, blood alcohol concentration, and operant self-administration in Gabra2 KO vs WT mice\",\n      \"pmids\": [\"23115637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific receptor subtype composition (α2βxγx) mediating ethanol sensitivity not defined\", \"Whether compensatory upregulation of other subunits contributes to phenotype not examined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Multiple convergent findings established broader roles: rs279858*C allele reduces GABRA2 expression in human iPSC-derived neurons in a developmental window; α2 KO abolishes methylphenidate-facilitated conditioned reinforcement; and gabra2 knockdown in zebrafish disrupts neural proliferation and proneural gene expression, indicating roles beyond mature synaptic inhibition.\",\n      \"evidence\": \"Human iPSC qPCR/RNA-seq genotype-stratified analysis; mouse KO operant behavior; zebrafish morpholino knockdown with proliferation/apoptosis/gene expression assays\",\n      \"pmids\": [\"26250693\", \"26635556\", \"29124181\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Developmental signaling role in mammalian neurogenesis not confirmed with genetic models\", \"iPSC expression effect not replicated in adult brain—developmental specificity vs technical limitation unclear\", \"Morpholino off-target effects not excluded by genetic mutant\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"H3K9me3 enrichment at the Gabra2 promoter and its sensitivity to SUV39H1 inhibition identified an epigenetic layer of Gabra2 transcriptional regulation that operates in an age-dependent manner.\",\n      \"evidence\": \"ChIP for H3K9me3 at Gabra2 promoter, qPCR, and ETP69 pharmacological inhibition in young and aged mice\",\n      \"pmids\": [\"34970138\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal relationship between H3K9me3 and Gabra2 expression not established by genetic manipulation of the mark\", \"Cell-type specificity of epigenetic regulation not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Point-mutation knockin mice revealed that individual α2 residues control distinct facets of alcohol behavior—H101R escalates binge drinking, Q241M blunts chronic intake, S270H/L277A prevents abstinence-induced social deficits—decomposing the receptor's pharmacological interfaces into separable behavioral outputs.\",\n      \"evidence\": \"Multiple knockin lines assessed with drinking-in-the-dark, continuous access, intermittent access, and social approach paradigms\",\n      \"pmids\": [\"27717041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Electrophysiological consequences of each knockin mutation on receptor function in vivo not measured\", \"Whether these residues act via allosteric modulation or direct ethanol binding not distinguished\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of a de novo p.T292K variant that produces tonically open channels with reduced expression in vitro established the first gain-of-function disease mechanism for GABRA2, linking it to developmental and epileptic encephalopathy.\",\n      \"evidence\": \"Whole-cell patch-clamp in HEK293T cells expressing mutant α2β3γ2 receptors\",\n      \"pmids\": [\"29961870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation of tonic opening in neuronal context not performed\", \"Whether tonic current causes excitotoxicity or shunting inhibition defect not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"FRMD7 was identified as a direct binding partner of the α2 intracellular TM3–TM4 loop, with mutations disrupting binding and causing GABAA receptor mislocalization, revealing a trafficking/anchoring partner for α2-containing receptors relevant to infantile nystagmus syndrome.\",\n      \"evidence\": \"GST pull-down, co-immunoprecipitation, and C. elegans FRAP/locomotion rescue assays\",\n      \"pmids\": [\"32446246\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FRMD7 interaction is specific to α2 vs other GABAA α subunits not tested\", \"Mammalian in vivo validation of receptor mislocalization upon FRMD7 loss not shown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR correction of a hypomorphic intronic indel in Gabra2 (C57BL/6J) that halves α2 expression rescued seizure severity and survival in both Scn1a and Scn8a encephalopathy models, causally validating Gabra2 as a genetic modifier of epilepsy through regulation of inhibitory synaptic receptor abundance.\",\n      \"evidence\": \"QTL mapping, quantitative Western blot, CRISPR/Cas9 allele correction, seizure/survival phenotyping in Scn1a+/− and Scn8a mutant mice\",\n      \"pmids\": [\"34086081\", \"33140451\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the modifier effect extends to other genetic epilepsies not tested\", \"Specific synaptic vs extrasynaptic receptor populations affected not distinguished\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Correction of the same Gabra2 intronic variant reduced methamphetamine-induced locomotor sensitization, extending the gene's modifier role beyond epilepsy to psychostimulant behavioral responses and confirming the causal QTL variant.\",\n      \"evidence\": \"Genome-wide QTL analysis, cis-eQTL mapping in striatum, CRISPR allele correction, methamphetamine locomotor assay\",\n      \"pmids\": [\"34677900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream circuit mechanism linking reduced α2 expression to enhanced psychostimulant sensitivity unclear\", \"Whether dopaminergic or GABAergic neurons are the critical cell type not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A novel p.A308V variant was shown to reduce α2 protein expression and impair co-immunoprecipitation with GABRB3 and GABRG2, establishing a loss-of-function mechanism through disrupted pentameric subunit assembly distinct from the gain-of-function tonic opening mechanism.\",\n      \"evidence\": \"Western blotting, co-immunoprecipitation, and immunofluorescence in transfected HEK293T cells\",\n      \"pmids\": [\"39737842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Electrophysiological characterization of p.A308V not performed\", \"Assembly defect not confirmed in neurons or brain tissue\", \"Only one variant tested—generalizability to other extracellular-domain mutations unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for how individual α2 residues differentially transduce benzodiazepine, neurosteroid, and ethanol modulation into distinct behavioral outputs, and which neuronal populations and synaptic vs extrasynaptic receptor pools mediate each pharmacological phenotype, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the α2-containing receptor with drug ligands\", \"Cell-type-specific conditional knockouts not yet reported\", \"Developmental vs adult contributions of α2 to circuit function not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 3, 4, 6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 9, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 4, 5, 6, 7]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 13]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 6]}\n    ],\n    \"complexes\": [\n      \"GABAA receptor (α2βγ pentamer)\"\n    ],\n    \"partners\": [\n      \"GABRB3\",\n      \"GABRG2\",\n      \"FRMD7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}